- call +1-201-465-4211
- email sales@mrinsights.biz
Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.
Scope of the Report:
Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of the primary neurotransmitters in the brain known as gamma amino butyric acid (GABA). An increase in GABA has a sedative effect on the user’s brain. The effect of barbiturate lasts between 4 hours and 16 hours, depending on the type and strength of the dose.
Barbiturates become dangerous when combined with other depressants such as alcohol. There is a high risk of dependency from regular use of barbiturate drugs. This can be a physical dependency, psychological dependency, or both. The amount required for overdose varies from person to person.
North America is expected to account for the largest share of the global market from 2018 to 2025, due to highest percentage of insomnia affected patients.
The worldwide market for Barbiturate Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Barbiturate Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
Merck
Eli Lilly
Mylan
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Valeant Pharmaceuticals
Oak Pharmaceuticals
Meda pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ultra-Short Acting Barbiturate
Short-Acting Barbiturate
Long-Acting Barbiturate
Combination Drugs
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
There are 15 Chapters to deeply display the global Barbiturate Drugs market.
Chapter 1, to describe Barbiturate Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Barbiturate Drugs, with sales, revenue, and price of Barbiturate Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Barbiturate Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Barbiturate Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Barbiturate Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Barbiturate Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Ultra-Short Acting Barbiturate
1.2.2 Short-Acting Barbiturate
1.2.3 Long-Acting Barbiturate
1.2.4 Combination Drugs
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Barbiturate Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Barbiturate Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Barbiturate Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Barbiturate Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Barbiturate Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical
2.6.1 Business Overview
2.6.2 Barbiturate Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Pharmaceutical Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sumitomo Dainippon Pharma
2.7.1 Business Overview
2.7.2 Barbiturate Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sumitomo Dainippon Pharma Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Valeant Pharmaceuticals
2.8.1 Business Overview
2.8.2 Barbiturate Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Valeant Pharmaceuticals Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Oak Pharmaceuticals
2.9.1 Business Overview
2.9.2 Barbiturate Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Oak Pharmaceuticals Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Meda pharmaceuticals
2.10.1 Business Overview
2.10.2 Barbiturate Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Meda pharmaceuticals Barbiturate Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Barbiturate Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Barbiturate Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Barbiturate Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Barbiturate Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Barbiturate Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Barbiturate Drugs Market Analysis by Regions
4.1 Global Barbiturate Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Barbiturate Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Barbiturate Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Barbiturate Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Barbiturate Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Barbiturate Drugs Sales and Growth Rate (2013-2018)
4.5 South America Barbiturate Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Barbiturate Drugs Sales and Growth Rate (2013-2018)
5 North America Barbiturate Drugs by Countries
5.1 North America Barbiturate Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Barbiturate Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Barbiturate Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Barbiturate Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Barbiturate Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Barbiturate Drugs Sales and Growth Rate (2013-2018)
6 Europe Barbiturate Drugs by Countries
6.1 Europe Barbiturate Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Barbiturate Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Barbiturate Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Barbiturate Drugs Sales and Growth Rate (2013-2018)
6.3 UK Barbiturate Drugs Sales and Growth Rate (2013-2018)
6.4 France Barbiturate Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Barbiturate Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Barbiturate Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Barbiturate Drugs by Countries
7.1 Asia-Pacific Barbiturate Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Barbiturate Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Barbiturate Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Barbiturate Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Barbiturate Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Barbiturate Drugs Sales and Growth Rate (2013-2018)
7.5 India Barbiturate Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Barbiturate Drugs Sales and Growth Rate (2013-2018)
8 South America Barbiturate Drugs by Countries
8.1 South America Barbiturate Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Barbiturate Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Barbiturate Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Barbiturate Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Barbiturate Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Barbiturate Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Barbiturate Drugs by Countries
9.1 Middle East and Africa Barbiturate Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Barbiturate Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Barbiturate Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Barbiturate Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Barbiturate Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Barbiturate Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Barbiturate Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Barbiturate Drugs Sales and Growth Rate (2013-2018)
10 Global Barbiturate Drugs Market Segment by Type
10.1 Global Barbiturate Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Barbiturate Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Barbiturate Drugs Revenue and Market Share by Type (2013-2018)
10.2 Ultra-Short Acting Barbiturate Sales Growth and Price
10.2.1 Global Ultra-Short Acting Barbiturate Sales Growth (2013-2018)
10.2.2 Global Ultra-Short Acting Barbiturate Price (2013-2018)
10.3 Short-Acting Barbiturate Sales Growth and Price
10.3.1 Global Short-Acting Barbiturate Sales Growth (2013-2018)
10.3.2 Global Short-Acting Barbiturate Price (2013-2018)
10.4 Long-Acting Barbiturate Sales Growth and Price
10.4.1 Global Long-Acting Barbiturate Sales Growth (2013-2018)
10.4.2 Global Long-Acting Barbiturate Price (2013-2018)
10.5 Combination Drugs Sales Growth and Price
10.5.1 Global Combination Drugs Sales Growth (2013-2018)
10.5.2 Global Combination Drugs Price (2013-2018)
11 Global Barbiturate Drugs Market Segment by Application
11.1 Global Barbiturate Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Retail Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 Barbiturate Drugs Market Forecast (2018-2023)
12.1 Global Barbiturate Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Barbiturate Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Barbiturate Drugs Market Forecast (2018-2023)
12.2.2 Europe Barbiturate Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Barbiturate Drugs Market Forecast (2018-2023)
12.2.4 South America Barbiturate Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Barbiturate Drugs Market Forecast (2018-2023)
12.3 Barbiturate Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Barbiturate Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Barbiturate Drugs Market Share Forecast by Type (2018-2023)
12.4 Barbiturate Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Barbiturate Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Barbiturate Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Barbiturate Drugs Picture
Table Product Specifications of Barbiturate Drugs
Figure Global Sales Market Share of Barbiturate Drugs by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
